The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients.
Herein, we aimed to identify the immunomodulatory role of tumor Syndecan-1 (CD138) in the polarization of CD4+ T helper (Th) subsets isolated from the tumor microenvironment of inflammatory breast cancer (IBC) and non-IBC patients. Lymphocytes and mononuclear cells isolated from the axillary tributa...
Main Authors: | Moshira Ezzat Saleh, Ramy Gadalla, Hebatallah Hassan, Ahmed Afifi, Martin Götte, Mohamed El-Shinawi, Mona Mostafa Mohamed, Sherif Abdelaziz Ibrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0217550 |
Similar Items
-
Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas
by: Mennatullah El-Nadi, et al.
Published: (2020-05-01) -
Syndecan-1 (CD138), Carcinomas and EMT
by: John R. Couchman
Published: (2021-04-01) -
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues
by: Simon Kind, et al.
Published: (2019-01-01) -
THE NEW DIAGNOSTIC FEATURES OF CD138 (SYNDECAN-1) IN MULTIPLE MYELOMA
by: A. F. Karamysheva
Published: (2015-12-01) -
Epithelial and Stromal Expression of Syndecan-1 (CD138) in Cutaneous Basal Cell Carcinoma
by: Vladimír BARTOŠ, et al.
Published: (2017-04-01)